Innovations Urgently Needed in Feline Diabetes Care, Caregiver’s Experience Highlights Critical Gaps

March 19, 2026 – The diagnosis of a chronic illness in a beloved pet often marks the beginning of a challenging journey for caregivers, a reality powerfully underscored by Katia Colitti’s four-year experience managing her cat Mosi’s feline diabetes. Diagnosed at the age of 17, Mosi’s condition presented a continuous series of practical and emotional hurdles for Colitti, a Ukrainian-American lawyer and animal welfare expert. Her reflections reveal significant gaps in current feline diabetes care, calling for species-specific innovations in monitoring technology, refined injection protocols, and more comprehensive, accessible veterinary guidance. Colitti’s insights, shared as part of the EveryCat Health Foundation’s 2026 “Springing into Action” campaign, resonate with countless pet owners navigating the complexities of chronic animal disease.

The Prevalence and Challenges of Feline Diabetes

Feline diabetes mellitus is a growing health concern, with estimates suggesting it affects between 1 in 200 and 1 in 500 cats globally, and some studies indicating an incidence as high as 1 in 80 among certain populations. Predominantly resembling Type 2 diabetes in humans, it is often associated with obesity, age, and a sedentary lifestyle, leading to insulin resistance and inadequate insulin production. Effective management requires a delicate balance of diet, insulin administration, and consistent glucose monitoring to prevent life-threatening complications like hypoglycemia (dangerously low blood sugar) or diabetic ketoacidosis (a severe metabolic disturbance).

For dedicated caregivers like Colitti, the daily regimen of diabetes management transforms their home into a mini-clinic. Mosi’s diagnosis at an advanced age meant Colitti faced the compounded difficulties of managing a chronic condition in a geriatric cat, whose fragile health and existing comorbidities, such as arthritis, further complicated care protocols. Her narrative illuminates how even the most committed owners, armed with resources and professional veterinary support, can struggle against systemic limitations in veterinary medical tools and educational frameworks.

The Ordeal of Glucose Monitoring: A Call for Feline-Specific Technology

Central to Colitti’s challenges was the arduous process of glucose monitoring. The gold standard for managing feline diabetes involves regular blood glucose measurements to tailor insulin doses, a task that proved "excruciatingly difficult" for Mosi and her owner. Traditional methods involve obtaining blood samples from the cat’s ear or paw pad. Colitti recounted her discomfort with using larger-gauge needles necessary for paw pad sampling, a technique often required due to the thicker skin and smaller blood vessels in feline paws compared to human fingers.

Ear sampling, while generally considered "easier," still presented a significant challenge. The procedure demands a calm, cooperative cat, a warmed ear to encourage blood flow without causing excessive bleeding (often achieved with a microwave-heated salt sock), and precise technique to prick near a vein. The subsequent race against time to collect a sufficient blood sample on a tiny measuring strip before it clots, all while keeping the cat still, frequently resulted in failed attempts, error messages, and repeated pricks. Colitti’s heartbreaking admission of making Mosi wince, and her own frustration-induced tears, highlight the profound emotional toll on both pet and owner.

Over time, Mosi’s ears developed scarring, a common consequence of repeated pricking. A particularly severe incident resulted in accidental damage to a vein, leading to necrosis and the eventual loss of the tip of Mosi’s left ear. This traumatic event, for which surgery was not an option given Mosi’s age and frailty, underscored the inherent invasiveness and potential for harm in existing monitoring practices.

The promise of continuous glucose monitors (CGMs), widely adopted in human diabetes care, offered a beacon of hope. However, human-designed CGMs, used off-label in veterinary medicine, proved unreliable and impractical for Mosi. Colitti attempted three different devices, each requiring shaving, surgical glue, and stressful removal from Mosi’s "fragile skin." The small shirts used to secure the devices restricted Mosi’s movement, exacerbating her arthritis discomfort. The consistent malfunction of these devices, failing well before their promised 14-day lifespan, led Colitti to conclude that the stress and invasiveness outweighed any potential benefit.

This experience firmly articulates the urgent need for CGMs "designed specifically for cats: tailored to feline body morphology, smaller, lighter, and gentle enough for thin or elderly cats." Such devices must be "easy to apply and remove at home" and, critically, "work reliably." Furthermore, Colitti discovered that the human glucometer recommended by her veterinarians, while convenient, might not provide the most accurate readings due to physiological differences between species. Feline blood has a higher hematocrit (red blood cell volume) and different glucose metabolism, meaning meters calibrated for human blood can give misleading results. Her brief, confusing attempt to switch to an animal-calibrated meter, with its unfamiliar scale and instructions, speaks to a broader lack of user-friendly, cat-specific diagnostic tools in the market.

Optimizing Insulin Administration: Addressing Real-World Challenges

Insulin injections, the cornerstone of diabetes treatment, also presented evolving challenges. Initially, Colitti and Mosi established a routine. However, the recommended practice of alternating injection sites proved impossible, as different areas caused Mosi discomfort. This limitation often led to localized tissue changes and further stress.

The advent of insulin injection pens offered a potential improvement in ease of use and dosage accuracy. Yet, this option was immediately dismissed for Mosi due to a specific auditory disorder that caused seizures in response to loud clicking noises, a common feature of these devices. This highlights how individual pet needs can render even seemingly advanced solutions unsuitable.

As Mosi entered her final year, marked by significant weight loss, injections became exceedingly complicated. The dwindling subcutaneous fat made it difficult to ensure the insulin was injected beneath the skin rather than into the fur, leading to wasted doses and uncertainty. Standard veterinary advice strictly cautions against re-injecting in such cases due to the risk of life-threatening hypoglycemia from a potentially double dose. Colitti rigidly adhered to this, often feeling she was risking Mosi’s health by not delivering the full dose, yet terrified of accidental overdose.

Her search for guidance specific to injecting thin or frail cats yielded little success; most instructional videos featured "cats of average weight with generous skin folds." This lack of practical, nuanced advice for geriatric or emaciated animals forced Colitti to resort to shaving the area between Mosi’s shoulder blades – a measure that, while effective, added another layer of complexity and stress.

Colitti’s experience advocates for the development of "better, quieter injection pens designed for feline use" and, crucially, "clear, practical guidance for injecting thin or frail cats, not just easy, perfect examples." The reality of aging pets and weight loss must be reflected in care instructions, moving beyond idealized scenarios to address the actual challenges faced by caregivers.

Bridging the Veterinary Guidance Gap: Enhancing Education and Support

Despite regular appointments at a "large, reputable clinic," including consultations with a diabetes specialist, Colitti frequently felt a deficit in comprehensive and consistent veterinary guidance. This is a common sentiment among owners managing chronic conditions, where the volume of information at diagnosis can be overwhelming, and ongoing support can be fragmented.

Specific examples of inconsistent or incomplete advice included:

• Syringe Reuse: Initial instruction to reuse syringes twice, later contradicted by concerns over insulin contamination and conflicting online information. The Centers for Disease Control and Prevention (CDC) and many medical professionals strongly advise against needle reuse in humans due to increased risk of infection, dulling of the needle, and potential for medication contamination. While some veterinary practices historically allowed limited reuse for cost savings, this practice is increasingly scrutinized for safety and efficacy.
• Injection Technique: A crucial detail like holding the needle bevel-side up to reduce discomfort was learned through independent online research, not from her clinic.
• Insulin Stability: The critical detail of discarding insulin vials after 20 days was discovered only by painstakingly reading the "tiny print on the vial," a detail often overlooked in initial consultations.
• Early Remission Potential: Perhaps most significantly, Colitti learned "too late that early, tightly regulated treatment in the first months after diagnosis can sometimes lead to remission in cats." This crucial window of opportunity, often referred to as "diabetic remission" or "transient diabetes," allows some cats, particularly those whose diabetes is induced by obesity and insulin resistance, to achieve normoglycemia without insulin therapy if managed aggressively early on. Missing this information deprived Mosi of a potential pathway to a less intervention-heavy life.

Colitti, a "dedicated, proactive, and well-resourced caregiver" who frequently sought help, still felt "alone in our fight against diabetes." Her experience underscores the need for more comprehensive, structured information at diagnosis and through follow-ups. She proposes that for caretakers of animals with chronic illnesses, clinics could offer "video consultations or subscription-style access to a veterinarian or veterinary nurse for ongoing support." This model could provide crucial "real-time guidance tailored to her situation," addressing the immediate, evolving challenges of chronic disease management that standard appointment structures often fail to capture.

Broader Implications and the Path Forward

Katia Colitti’s poignant narrative, while deeply personal, reflects a systemic need for advancement in veterinary care, particularly for chronic conditions. The implications extend far beyond individual pet owners and their animals:

• Enhanced Animal Welfare: Improved tools and education would significantly reduce stress, discomfort, and potential harm to diabetic cats, leading to a higher quality of life and potentially longer lifespans. Accurate monitoring prevents dangerous glycemic fluctuations, while better injection methods minimize pain and anxiety.
• Alleviated Caregiver Burden: The emotional and practical toll on owners managing chronic pet illnesses is immense. Simplifying procedures, providing reliable tools, and offering consistent support can reduce caregiver burnout, improve adherence to treatment plans, and foster a stronger human-animal bond. This, in turn, can positively impact the mental health of pet owners, acknowledging their vital role as primary caregivers.
• Advancements in Veterinary Medicine: Colitti’s call for species-specific technology highlights a broader need for innovation in veterinary medical device development. The veterinary field often lags behind human medicine in terms of specialized tools and research funding. Her experience makes a strong case for increased investment in research and development tailored to the unique physiological and behavioral aspects of different animal species.
• Refined Educational Paradigms: The inconsistencies in veterinary advice point to a need for standardized, continuously updated educational protocols for both veterinary professionals and pet owners. The rapid evolution of medical knowledge necessitates ongoing professional development and effective methods for disseminating critical information to caregivers in an accessible, understandable format. The potential for telehealth and subscription-based support models represents a paradigm shift in how chronic pet care can be delivered, moving towards more proactive and personalized support.

The EveryCat Health Foundation, through initiatives like The O’Malley Fund for Diabetes and Endocrinopathies, plays a crucial role in funding the research necessary to address these gaps. Investing in studies that explore novel monitoring technologies, refine insulin delivery methods, and enhance veterinary education can translate directly into practical improvements for diabetic cats and their caregivers. Colitti’s hope is that her experience, however challenging, will contribute to a future where feline diabetes care is less burdensome and more effective, ensuring that other families do not have to endure the same struggles. Her story is a powerful testament to the enduring bond between humans and their animal companions, and a compelling call to action for a more compassionate and technologically advanced approach to veterinary medicine.